PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE
LIVE

Serial Number

90558538

Owner

PRECISION MEDICINE GROUP, LLC

Attorney

Donna H. Hartman

First Use Date

Jan 14, 2021

Filing Date

Mar 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE Trademark

Serial Number: 90558538 • Registration: 6800412

PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE is a trademark filed by PRECISION MEDICINE GROUP, LLC on March 3, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PRECISION MEDICINE GROUP, LLC (145 trademarks)

BETHESDA, MD 20814

Entity Type: 16

Trademark Details

Filing Date

March 3, 2021

Registration Date

July 26, 2022

First Use Anywhere

January 14, 2021

First Use in Commerce

January 14, 2021

Published for Opposition

May 10, 2022

Goods & Services

Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry

Business management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business consulting services provided to the healthcare industry in the nature of the creation, collection, analysis, and reporting of data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition

Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 26, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 4, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2022 CNSA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jul 29, 2021 CEPE
ASSIGNED TO LIE
Jul 29, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2021 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 22, 2021 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 22, 2021 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jul 22, 2021 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jul 22, 2021 CPEA
ASSIGNED TO EXAMINER
Jul 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2021 NWOS
NEW APPLICATION ENTERED
Mar 6, 2021 NWAP